EMPLOYMENT AGREEMENTEmployment Agreement • May 1st, 2006 • Access Pharmaceuticals Inc • Pharmaceutical preparations • Texas
AGREEMENT dated as of June 1, 2005 between ACCESS Pharmaceuticals, Inc. a Delaware Corporation located at 2600 Stemmons Freeway, Suite 176, Dallas, Texas 75207-2107, (the “Company”), and Stephen B. Thompson, an individual residing at 4231 Bowser Avenue, Dallas, Texas 75219 (the “Executive”).
AMENDMENT TO RIGHTS AGREEMENTRights Agreement • May 1st, 2006 • Access Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Amendment to Rights Agreement, dated as of October 31, 2005 (the “Amendment”), is by and between Access Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and American Stock Transfer & Trust Company, a New York corporation (the “Rights Agent”), amending certain provisions of the Rights Agreement, dated as of October 31, 2001 (as amended and in effect from time to time, the “Agreement”), by and between the Company and the Rights Agent. Terms not otherwise defined herein which are defined in the Agreement shall have the same respective meanings herein as therein.
LICENSE AGREEMENTLicense Agreement • May 1st, 2006 • Access Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS LICENSE AGREEMENT (this “Agreement”) is made and entered into effective as of October 12, 2005 (the “Effective Date”), by and between Access Pharmaceuticals, Inc., a Delaware corporation (“Licensor”) and ULURU, Inc., a Delaware corporation (“Licensee”).
ASSET SALE AGREEMENTAsset Sale Agreement • May 1st, 2006 • Access Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS ASSET SALE AGREEMENT (the “Agreement”), is made as of the 12th day of October, 2005, by and between ULURU, Inc., a Delaware corporation (“ULURU”), and Access Pharmaceuticals, Inc., a Delaware corporation (“Access”). ULURU and Access are sometimes individually referred to herein as the “Party” and collectively as the “Parties.”
SEPARATION AGREEMENTSeparation Agreement • May 1st, 2006 • Access Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
THIS SEPARATION AGREEMENT between Access Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Kerry Gray (hereinafter referred to as “Gray”), dated as of May 10, 2005 (the “Effective Date”);
AMENDMENT TO 7.0% (SUBJECT TO ADJUSTMENT) CONVERTIBLE PROMISSORY NOTES DUE SEPTEMBER 13, 2005Access Pharmaceuticals Inc • May 1st, 2006 • Pharmaceutical preparations • Texas
This Amendment to 7.0% (Subject to Adjustment) Convertible Promissory Notes Due September 13, 2005, dated as of November 3, 2005 (the “Amendment”), is by and among Access Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and each of Oracle Partners LP, Oracle Institutional Partners LP, SAM Oracle Investments Inc. and Oracle Offshore Ltd. (each, a “Holder”), amending certain provisions of those certain 7.0% (Subject to Adjustment) Convertible Promissory Notes Due September 13, 2005 No. R-1 (each as amended and in effect from time to time, a “Note”) from the Company to each Holder in the original principal amount of $2,524,500, $698,500, $660,000 and $132,000, respectively. Terms not otherwise defined herein which are defined in any Note shall have the same respective meanings herein as therein.
